Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2020 3
2021 3
2022 6
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line.
Laus AC, Gomes INF, da Silva ALV, da Silva LS, Milan MB, AparecidaTeixeira S, Martin ACBM, do Nascimento Braga Pereira L, de Carvalho CEB, Crovador CS, de Paula FE, Nascimento FC, de Freitas HT, de Lima Vazquez V, Reis RM, da Silva-Oliveira RJ. Laus AC, et al. Among authors: da silva ls. Hum Cell. 2024 Apr 3. doi: 10.1007/s13577-024-01054-1. Online ahead of print. Hum Cell. 2024. PMID: 38565739
The digital expression profile of BMP7, CDKN2C, HIST1H3G, and PKMYT1 genes improves high-grade cervical lesion detection in liquid-based cytology.
Causin RL, Sussuchi da Silva L, Leal LF, Possati-Resende JC, Evangelista AF, Matsushita GM, Scapulatempo-Neto C, Tavares Guerreiro Fregnani JH, Antônio de Oliveira M, Musselwhite LW, Chiquitelli Marques MM, Reis RM. Causin RL, et al. Among authors: sussuchi da silva l. Cancer Cytopathol. 2023 Jul;131(7):454-464. doi: 10.1002/cncy.22704. Epub 2023 Apr 17. Cancer Cytopathol. 2023. PMID: 37069588
Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients' survival.
Moreno DA, da Silva LS, Gomes I, Leal LF, Berardinelli GN, Gonçalves GM, Pereira CA, Santana IVV, Matsushita MM, Bhat K, Lawler S, Reis RM. Moreno DA, et al. Among authors: da silva ls. Ther Adv Med Oncol. 2022 Dec 21;14:17588359221127678. doi: 10.1177/17588359221127678. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36579028 Free PMC article.
Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.
Lengert AVH, Pereira LDNB, Cabral ERM, Gomes INF, Jesus LM, Gonçalves MFS, Rocha AOD, Tassinari TA, Silva LSD, Laus AC, Vidal DO, Pinto MT, Reis RM, Lopes LF. Lengert AVH, et al. Among authors: silva lsd. Front Biosci (Landmark Ed). 2022 Aug 16;27(8):245. doi: 10.31083/j.fbl2708245. Front Biosci (Landmark Ed). 2022. PMID: 36042160 Free article.
Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study.
Moreno DA, da Silva LS, Zanon MF, Bonatelli M, de Paula FE, de Medeiros Matsushita M, Teixeira GR, Santana IVV, Saggioro F, Neder L, Stavale JN, Malheiros SMF, Lima M, Hajj GNM, Garcia-Rivello H, Christiansen S, Nunes S, da Costa MJG, Soares MJ, Pinheiro J, Junior CA, Mançano BM, Reis RM. Moreno DA, et al. Among authors: da silva ls. J Neurooncol. 2022 Mar;157(1):27-35. doi: 10.1007/s11060-022-03965-1. Epub 2022 Feb 15. J Neurooncol. 2022. PMID: 35166989
17 results